Evidence map›Paper›PMID 25911754›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

CD8+ TCR Bias and Immunodominance in HIV-1 Infection.

Henrik N Kløverpris, Reuben McGregor, James E McLaren, Kristin Ladell, Mikkel Harndahl, Anette Stryhn, Jonathan M Carlson, Catherine Koofhethile, Bram Gerritsen, Can Keşmir and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Systematic, Unbiased Mapping of CD8Frontiers in immunology · 2020
    Article
  9. Article
  10. Article
  11. Immune Control of HIV.Journal of life sciences (Westlake Village, Calif.) · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. T Cell Receptor Profiling in Type 1 Diabetes.Current diabetes reports · 2017
    Review
  17. Article
  18. Article
  19. Role of HLA Adaptation in HIV Evolution.Frontiers in immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 7 countries.

Henrik N KløverprisDepartment of Paediatrics, University of Oxford, Oxford OX1 3SY, United Kingdom; Department of International Health, Immunology, and Microbiology, University of Copenhagen, 2200-Copenhagen N, Denmark; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa; henrik.kloverpris@k-rith.org.
Reuben McGregorDepartment of Paediatrics, University of Oxford, Oxford OX1 3SY, United Kingdom;
James E McLarenInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Kristin LadellInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Mikkel HarndahlDepartment of International Health, Immunology, and Microbiology, University of Copenhagen, 2200-Copenhagen N, Denmark;
Anette StryhnDepartment of International Health, Immunology, and Microbiology, University of Copenhagen, 2200-Copenhagen N, Denmark;
Jonathan M CarlsonMicrosoft Research, eScience Group, Los Angeles, CA 90024;
Catherine KoofhethileHIV Pathogenesis Program, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4013, South Africa;
Bram GerritsenTheoretical Biology Group, Utrecht University, 3584 CH Utrecht, the Netherlands;
Can KeşmirTheoretical Biology Group, Utrecht University, 3584 CH Utrecht, the Netherlands;
Fabian ChenDepartment of Sexual Health, Royal Berkshire Hospital, Reading RG1 5AN, United Kingdom;
Lynn RiddellDepartment of Genitourinary Medicine, Northamptonshire Healthcare National Health Service Trust, Northampton General Hospital, Cliftonville, Northampton NN1 5BD, United Kingdom;
Graz LuzziDepartment of Sexual Health, Wycombe Hospital, High Wycombe HP11 2TT, United Kingdom;
Alasdair LeslieKwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa;
Bruce D WalkerRagon Institute of MGH, MIT, and Harvard, Boston, MA 02129; Howard Hughes Medical Institute, Chevy Chase, MD 20815; and.
Thumbi Ndung'uKwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa; HIV Pathogenesis Program, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4013, South Africa; Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.
Søren BuusDepartment of International Health, Immunology, and Microbiology, University of Copenhagen, 2200-Copenhagen N, Denmark;ORCID http://orcid.org/0000-0001-8363-1999
David A PriceInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Philip J GoulderDepartment of Paediatrics, University of Oxford, Oxford OX1 3SY, United Kingdom;
University of Copenhagen · DKInstitute of Infection and Immunity · CAUniversity of Applied Sciences Utrecht · NLUniversity of KwaZulu-Natal · ZAUniversity of Oxford · GBHoward Hughes Medical Institute · USMax Planck Institute for Infection Biology · DEMicrosoft (United States) · USNational Health Service · GBRoyal Berkshire Hospital · GBWycombe General Hospital · GB

Funding

Optimizing CD8+ T-cell responses against C clade HIV infection in subSaharan AfriR01AI046995 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2000 to 2014
$6.8M
NIAID NIH HHS R01 AI046995NIAID NIH HHS R01 AI46995Wellcome Trust 082369Wellcome Trust 100326Wellcome Trust 104748
6 · The paper itself

Abstract

Immunodominance describes a phenomenon whereby the immune system consistently targets only a fraction of the available Ag pool derived from a given pathogen. In the case of CD8(+) T cells, these constrained epitope-targeting patterns are linked to HLA class I expression and determine disease progression. Despite the biological importance of these predetermined response hierarchies, little is known about the factors that control immunodominance in vivo. In this study, we conducted an extensive analysis of CD8(+) T cell responses restricted by a single HLA class I molecule to evaluate the mechanisms that contribute to epitope-targeting frequency and antiviral efficacy in HIV-1 infection. A clear immunodominance hierarchy was observed across 20 epitopes restricted by HLA-B*42:01, which is highly prevalent in populations of African origin. Moreover, in line with previous studies, Gag-specific responses and targeting breadth were associated with lower viral load set-points. However, peptide-HLA-B*42:01 binding affinity and stability were not significantly linked with targeting frequencies. Instead, immunodominance correlated with epitope-specific usage of public TCRs, defined as amino acid residue-identical TRB sequences that occur in multiple individuals. Collectively, these results provide important insights into a potential link between shared TCR recruitment, immunodominance, and antiviral efficacy in a major human infection.

Indexed as

AdultAmino Acid SequenceAntibody AffinityBase SequenceCD8-Positive T-LymphocytesDNA, ComplementaryEpitope MappingEpitopes, T-LymphocyteFemalegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHLA-B AntigensHumansImmunodominant EpitopesReceptors, Antigen, T-CellDNA, ComplementaryEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusHLA-B AntigensImmunodominant EpitopesReceptors, Antigen, T-Cell

Identifiers

PMID25911754
PMCPMC4433859
OpenAlexW1544638309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.